文献速递区域麻醉与超声疼痛医学

右美托咪定与地塞米松不同途径对锁骨上臂丛阻滞的网状Meta分析

Perineural and intravenous dexamethasone and dexmedetomidine: network meta-analysis of adjunctive effects on supraclavicular brachial plexus block.
PubMed 文献 · Anaesthesia · 2020-10-28

主要结局为感觉阻滞持续时间,差异2小时视为临床重要。结果显示地塞米松无论途径均比右美托咪定更显著延长感觉和镇痛阻滞,静脉右美托咪定无效,神经周围与静脉地塞米松差异无临床重要性。

要点

  • 地塞米松(无论途径)延长感觉和镇痛阻滞优于右美托咪定。
  • 静脉右美托咪定不延长感觉、运动或镇痛阻滞持续时间。
  • 神经周围与静脉地塞米松的阻滞特征差异无临床重要性。

核心结论

  • 地塞米松作为佐剂延长锁骨上臂丛感觉和镇痛阻滞的程度大于右美托咪定,且与给药途径无关。
  • 神经周围与静脉地塞米松之间的阻滞特征差异无临床重要性。
  • 静脉右美托咪定不影响阻滞特征。

研究设计与样本

  • 研究对象为接受锁骨上臂丛阻滞并使用长效局部麻醉药的患者。
  • 比较神经周围或静脉注射地塞米松或右美托咪定作为佐剂的效果。
  • 主要结局为感觉阻滞持续时间,临床重要差异阈值为2小时。
  • 采用频率学分析,使用GRADE框架评估证据质量。

主要发现

  • 对照组(单用局部麻醉药)感觉阻滞持续时间为401(95%CI 366-435)分钟,运动阻滞369(95%CI 330-408)分钟,镇痛持续时间435(95%CI 386-483)分钟。
  • 与对照组相比,感觉阻滞延长最多为静脉地塞米松(平均差477分钟,95%CI 160-795),其次为神经周围地塞米松(411分钟,95%CI 343-480)和神经周围右美托咪定(284分钟,95%CI 235-333)。
  • 运动阻滞延长最多为神经周围地塞米松(平均差294分钟,95%CI 236-352),其次为静脉地塞米松(289分钟,95%CI 129-448)和神经周围右美托咪定(258分钟,95%CI 212-304)。
  • 镇痛持续时间延长最多为神经周围地塞米松(平均差518分钟,95%CI 448-589),其次为静脉地塞米松(478分钟,95%CI 277-679)和神经周围右美托咪定(318分钟,95%CI 266-371)。
  • 静脉右美托咪定未延长感觉、运动或镇痛阻滞持续时间。

关键数值与推荐

  • 静脉地塞米松、神经周围地塞米松和神经周围右美托咪定延长锁骨上感觉阻滞持续时间的证据质量分别为「低」、「极低」和「低」。
  • 未发现主要的网状不一致性。

临床怎么用

  • 临床选择佐剂时,地塞米松无论神经周围或静脉途径均可显著延长感觉和镇痛阻滞,且两者差异无临床重要性。
  • 静脉右美托咪定不宜用于延长锁骨上臂丛阻滞。
  • 证据质量较低,应用时需结合临床实际情况。

局限性

  • 静脉地塞米松延长感觉阻滞的证据质量为「低」。
  • 神经周围地塞米松的证据质量为「极低」。
  • 神经周围右美托咪定的证据质量为「低」。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Both perineural and intravenous dexamethasone and dexmedetomidine are used as local anaesthetic adjuncts to enhance peripheral nerve block characteristics. However, the effects of dexamethasone and dexmedetomidine based on their administration routes have not been directly compared, and the relative extent to which each adjunct prolongs sensory blockade remains unclear. This network meta-analysis sought to compare and rank the effects of perineural and intravenous dexamethasone and dexmedetomidine as supraclavicular block adjuncts. We sought randomised trials investigating the effects of adding perineural and intravenous dexamethasone or dexmedetomidine to long-acting local anaesthetics on supraclavicular block characteristics, including time to block onset and durations of sensory, motor and analgesic blockade. Data were compared and ranked according to relative effectiveness for each outcome. Our primary outcome was sensory block duration, with a 2-h difference considered clinically important. We performed a frequentist analysis, using the GRADE framework to appraise evidence. One-hundred trials (5728 patients) were included. Expressed as mean (95%CI), the control group (local anaesthetic alone) had a duration of sensory block of 401 (366-435) min, motor block duration of 369 (330-408) min and analgesic duration of 435 (386-483) min. Compared with control, sensory block was prolonged most by intravenous dexamethasone [mean difference (95%CI) 477 (160-795) min], followed by perineural dexamethasone [411 (343-480) min] and perineural dexmedetomidine [284 (235-333) min]. Motor block was prolonged most by perineural dexamethasone [mean difference (95%CI) 294 (236-352) min], followed by intravenous dexamethasone [289 (129-448)min] and perineural dexmedetomidine [258 (212-304)min]. Analgesic duration was prolonged most by perineural dexamethasone [mean difference (95%CI) 518 (448-589) min], followed by intravenous dexamethasone [478 (277-679) min] and perineural dexmedetomidine [318 (266-371) min]. Intravenous dexmedetomidine did not prolong sensory, motor or analgesic block durations. No major network inconsistencies were found. The quality of evidence for intravenous dexamethasone, perineural dexamethasone and perineural dexmedetomidine for prolongation of supraclavicular sensory block duration was 'low', 'very low' and 'low', respectively. Regardless of route, dexamethasone as an adjunct prolonged the durations of sensory and analgesic blockade to a greater extent than dexmedetomidine. Differences in block characteristics between perineural and intravenous dexamethasone were not clinically important. Intravenous dexmedetomidine did not affect block characteristics.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Sehmbi H, Brull R, Ceballos KR, et al. Perineural and intravenous dexamethasone and dexmedetomidine: network meta-analysis of adjunctive effects on supraclavicular brachial plexus block. Anaesthesia. 2020. PMID: 33118163. doi:10.1111/anae.15288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。